By Julia Karow
This story was originally published Sept. 22.
The Ion Torrent technology that Life Technologies recently acquired will be suitable in the long term for single-molecule analysis, and will enable the company to "revolutionize" the genetic-testing market, Life Tech chairman and CEO Greg Lucier said during the UBS Global Life Sciences Conference in New York last week.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
